5Zangari M, Elice F, Fink L, et al. Thrombosis in multiple myeloma [ J ]. Anticancer Ther, 2007,7 ( 3 ) : 307 -315.
6Kristinsson S Y, Pfeiffer R M, Bjorkholm M, et al. Arterial and venous thrombosis in monoclonal gammopathy of unde- termined significance and multiple myeloma: a population- based study [ J ]. Blood, 2010,115 ( 24 ) :4991-4998.
7Zamagni E, Brioli A, Tacchetti P, et al. Multiple myeloma, venous thromboembolism, and treatment-related risk of throm- bosis[J]. Semin Thromb Hemost, 2011,37(3) :209-219.
8Auwerda J J, Sonneveld P, de Maat M P, et al. Prothrom- boric coagulation abnormalities in patients with paraprotein- producing B-cell disorders [ J ]. Clin Lymphoma Myeloma, 2007 (7) :462-466.
9Kristinsson S Y. Thrombosis in multiple myeloma[J]. Hematol- ogy Am Soc Hematol Educ Program, 2010(2010) :437-444.
10Elice F. Fink L, Tricot G, et al. Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transi- tory abnormality associated with an increased risk of venous thrombombolism [ J ]. Br J Haem.ttol, 2006,134 (4) :399-405.
